Abstract
Combined hepatocellular-cholangiocarcinoma (CHCC-C) is defined as a tumor that contains unequivocal, intimately mixed elements of both hepatocellular carcinoma and cholangiocarcinoma, resulting in a biphenotypic histologic picture. CHCC-C should not be confounded with collision tumors or rare hepatic mixed tumors. This is a rare liver malignancy of older individuals, probably accounting for less than 5 % of hepatic malignancies. The neoplasm develops in both non-cirrhotic and cirrhotic livers. Etiologic factors include hepatitis virus infections and alcoholic liver disease.
CHCC-C usually presents as a solitary tumor mass. Similar to hepatocellular carcinoma, the tumor tends to invade the portal vein system and bile ducts. Based on distinct histologic patterns, several types of CHCC-C are distinguished in the WHO classification, including a classical type and a type with stem cell features, the latter further subdivided into at least four subtypes. Rare variants of CHCC-C contain sarcomatoid components, or the HCC component is that of fibrolamellar hepatocellular carcinoma. CHCC-Cs are usually highly aggressive lesions with a high rate of metastatic spread.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aishima S, Kuroda Y, Asayama Y, Taguchi K, Nishihara Y, Taketomi A, Tsuneyoshi M (2006) Prognostic impact of cholangiocellular and sarcomatous components in combined hepatocellular and cholangiocarcinoma. Hum Pathol 37:283–291
Akiba J, Nakashima O, Hattori S, Tanikawa S, Takenaka M, Nakayama M, Kondo R, Nomura Y, Koura K et al (2013) Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification. Am J Surg Pathol 37:496–505
Allen RA, Lisa JR (1949) Combined liver cell and bile duct carcinoma. Am J Pathol 25:647–655
Amano H, Itamoto T, Emoto K, Hino H, Asahara T, Shimamoto F (2005) Granulocyte colony-stimulating factor-producing combined hepatocellular/ cholangiocellular carcinoma with sarcomatous change. J Gastroenterol 40:1158–1159
Aoki K, Takayasu K, Kawano T, Muramatsu Y, Moriyama N, Wakao F, Yamamoto J et al (1993) Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features and computed tomographic findings. Hepatology 18:1090–1095
Ariizumi S, Kotera Y, Karagiri S, Nakano M, Yamamoto M (2012) Combined hepatocellular-cholangiocarcinoma had poor outcomes after hepatectomy regardless of Allen and Lisa class or the predominance of intrahepatic cholangiocarcinoma cells within the tumor. Ann Surg Oncol 19:1628–1636
Asayama Y, Taguchi KK, Aishima SS, Nishi H, Matsuda K, Tsuneyoshi M (2002) The mode of tumour progression in combined hepatocellular carcinoma and cholangiocarcinoma: an immunohistochemical analysis of E-cadherin, alpha-catenin and beta-catenin. Liver 22:43–50
Bedossa P (2007) Case 6: combined hepatocellular and cholangiocarcinoma (in French). Ann Pathol 27:112–114
Bhagat V, Javle M, Agrawal A, Gibbs JF, Kuvshinoff B, Nava E, Iyer R (2006) Combined hepatocholangiocarcinoma: case-series and review of literature. Int J Gastrointest Cancer 37:27–34
Bonne C (1937) Cancer and human races. Am J Cancer 30:435–454
Boonsakan P, Thangnapakorn O, Tapaneeyakorn J, Kositchaiwat S, Bunyaratvei S (2007) case report combined hepatocellular and cholangiocarcinoma with sarcomatous transformation. J Med Assoc Thai 90:574–580
Cabot J (1940) Case no. 26441. Primary cancer of the liver, combined type: adenocarcinoma and hepatoma. New Engl J Med 223:731–734
Cai X, Zhai J, Kalan DE, Zhang Y, Zhou L, Chen X, Qian G, Zhao Q, Li Y, Gao L et al (2012) background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular-cholangiocarcinoma. Hepatology 56:1804–1816
Cazals-Hatem D, Rebouissou S, Bioulac-Sage P, Bluteau O, Branché H, Franco D et al (2004) Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas. J Hepatol 41:292–298
Chantajitr S, Wilasrusmee C, Lertsitichai P, Phromsopha N (2006) Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population. J Hepatobiliary Pancreat Surg 13:537–542
Chi M, Mikhitarian K, Shi C, Goff LW (2012) Management of combined hepatocellular-cholangiocarcinoma: a case report and literature review. Gastrointest Cancer Res 5:199–202
Choi BI, Han JK, Kim YI, Kim HC, Park JH, Kim CW, Han MC (1994) Combined hepatocellular and cholangiocarcinoma of the liver: sonography, CT, angiography, and iodized-oil CT with pathologic correlation. Abdom Imaging 19:43–46
Chu KJ, Lu CD, Dong H, Fu XH, Zhang HW, Yao XP (2014) Hepatitis B virus-related combined hepatocellular-cholangiocarcinoma: clinicopathological and prognostic analysis of 390 cases. Eur J Gastroenterol Hepatol 26:192–199
De Campos RO, Semelka RC, Azevedo RM, Ramalho M, Heredia V, Armao DM, Woosley JT (2012) Combined hepatocellular carcinoma-cholangiocarcinoma: report of MR appearance in eleven patients. J Magn Reson Imaging 36:1139–1147
Deniz K, Torun E, Celikbilek M, Sözüer E (2011) Combined hepatocellular and cholangiocarcinoma associated with hepatolithiasis: report of a case. Surg Today 41:591–595
Dusenbery D (1997) Combined hepatocellular-cholangiocarcinoma. Cytologic findings in four cases. Acta Cytol 41:903–909
Ewing J (1940) Neoplastic diseases, 4th edn. W.B. Saunders Co., Philadelphia, p 740
Fisher HP, Doppel W, Osborn M, Altmannsberger M (1988) Evidence for a hepatocellular lineage in a combined hepatocellular-cholangiocarcinoma of transitional type. Virchows Arch B Cell Pathol Incl Mol Pathol 56:71–76
Fowler KJ, Sheybani A, Parker RA, Doherty S, Brunt M, Chapman WC, Menias CO (2013) Combined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRI. AJR Am J Roentgenol 201:332–339
Fujii H, Zhu XG, Matsumoto T, Inagaki M, Tokusashi Y, Miyokawa N, Fukusato T et al (2000) Genetic classification of combined hepatocellular-cholangiocarcinoma. Hum Pathol 31:1011–1017
Fukukura Y, Taguchi J, Nakashima O, Wada Y, Kojiro M (1997) Combined hepatocellular and cholangiocarcinoma: correlation between CT findings and clinicopathologic features. J Comput Assist Tomogr 21:52–58
Garancini M, Goffredo P, Pagni F, Romano F, Roman S, Sosa JA, Giardini V (2014) Combined hepatocellular-cholangiocarcinoma: a population-level analysis of an uncommon primary liver tumor. Liver Transpl 20:952–959
Gibbons D, de las Morenas A (1997) Fine needle aspiration diagnosis of combined hepatocellular carcinoma and cholangiocarcinoma. A case report. Acta Cytol 41(suppl):1269–1272
Goldzieher MA (1928) Über multiple Carcinome, ein Beitrag zur Frage der Histogenese des Lebercarcinoms. Virchows Arch Pathol Anat 267:326–338
Goodman ZD, Ishak KG, Langloss JM, Sesterhenn IA, Rabin L (1985) Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study. Cancer 55:124–135
Gustafsen E.G. (1937/38). An analysis of sixty-two cases of primary carcinoma of the liver based on 24’400 necropsies at Bellevue Hospital. Ann Int Med. 11:889–900
Hanazaki K, Fujimori Y, Kajikawa S, Nakata S, Shimozawa N, Adachi W, Amano J (1998) Mixed hepatocellular carcinoma and cholangiocarcinoma treated by extended left hepatic lobectomy with resection of the right hepatic vein and preservation of the inferior right hepatic vein after hepatic arterial infusion chemotherapy. Hepatogastroenterology 45:812–815
Harada K, Terada T, Nakanuma Y, Furukawa Y, Kurumaya H (1993) A case of small combined hepatocellular and cholangiocellular carcinoma arising in a nodule of atypical adenomatous hyperplasia of the liver. Am J Gastroenterol 88:1968–1969
Haratake J, Hashimoto H (1995) An immunohistochemical analysis of 13 cases with combined hepatocellular and cholangiocellular carcinoma. Liver 15:9–15
Hashimoto T, Nakamura H, Hori S, Tomoda K, Mitani T, Murakami T, Kozuka T, Monden M et al (1994) MR imaging of mixed hepatocellular and cholangiocellular carcinoma. Abdom Imaging 19:430–432
Hauben E, Struyf N, Michielsen P, van Marck E (1996) Cytokeratin profiles and mucin secretion in combined hepatocellular-cholangiocarcinoma. A case report. Pathol Res Pract 192:488–491
Hirohashi K, Uenishi T, Kubo S, Yamamoto T, Tanaka H, Shuto T, Kinoshita H (2002) The separate-lesion type combined hepatocellular carcinoma and cholangiocarcinoma. Hepatogastroenterology 49:806–809
Horie Y, Yamada M, Nakai K, Kawasaki H, Hirayama C, Matsui K, Kambe N, Shimao S (1989) Combined hepatocellular-cholangiocarcinoma associated with dermatomyositis. J Gastroenterol Hepatol 4:101–104
Hunt JP, Varnholt H (2008) Mixed hepatocellular-cholangiocarcinoma may derive from “hepatogones”. Hepatobiliary Pancreat Dis Int 7:105
Hwang J, Kim YK, Park MJ, Lee MH, Kim SH, Lee WJ, Rhim HC (2012) Differentiating combined hepatocellular and cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma using gadoxetic acid-enhanced MRI. J Magn Reson Imaging 36:881–889
Ikeda H, Harada K, Sato Y, Sasaki M, Yoneda N, Kitamura S, Sudo Y, Ooi A, Nakanuma Y (2013) Clinicopathologic significance of combined hepatocellular-cholangiocarcinoma with stem cell subtype components with reference to the expression of putative stem cell markers. Am J Clin Pathol 140:329–340
Imai Y, Oda H, Arai M, Shimizu S, Nakatsuru Y, Inoue T, Ishikawa T (1996) Mutational analysis of the p53 and K-ras genes and allelotype study of the Rb-1 gene for investigating the pathogenesis of combined hepatocellular-cholangiocellular carcinomas. Jpn J Cancer Res 87:1056–1062
Jarnagin WR, Weber S, Tickoo SK, Koea JB, Objekwe S, Fong Y, DelMatteo RP, Blumgart LH, Klimstra D (2002) Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors. Cancer 94:2040–2046
Jeong BJ, Hyun DH, Lee KW, Ryu ST, Lee JW, Lee JI, Jeong S, Lee DH, Kim PS, Kim HH, Kim YS, Kim JM (2004) A case of sarcomatoid combined hepatocellular-cholangiocarcinoma (in Korean). Korean J Gastroenterol 43:56–60
Kakar S, Muir T, Murphy LM, Lloyd RV, Burgart LJ (2003) Immunoreactivity of Hep Par 1 in hepatic and extrahepatic tumors and its correlation with albumin in situ hybridization in hepatocellular carcinoma. Am J Clin Pathol 119:361–366
Kanamoto M, Yoshizumi T, Ikegami T, Imura S, Morine Y, Ikemoto T, Sano N, Shimada M (2008) Cholangiolocellular carcinoma containing hepatocellular carcinoma and cholangiocellular carcinoma, extremely rare tumor of the liver: a case report. J Med Invest 55:161–165
Kassahun WT, Hauss J (2008) Management of combined hepatocellular and cholangiocarcinoma. Int J Clin Pract 62:1271–1278
Kilpatrick SE, Geisinger KR, Loggie BW, Hopkins MB (1993) Cytomorphology of combined hepatocellular-cholangiocarcinoma in fine needle aspirates of the liver. A report of two cases. Acta Cytol 37:943–947
Kim H, Park C, Han KH, Choi J, Kim YB, Kim JK, Park YN (2004a) Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype. J Hepatol 40:298–304
Kim JH, Lee YG, Lee J, Jung CK, Kim HT, Kang H, Kho KH, Hong SP, Hwang SG et al (2004b) A case of combined hepatocellular-cholangiocarcinoma with sarcomatous transformation and second primary colon cancer (in Korean). Kor J Hepatol 10:142–147
Kim KH, Lee SG, Park EH, Hwang S, Ahn CS, Moon DB, Ha TY, Song GW, Jung DH et al (2009) Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma. Ann Surg Oncol 16:623–629
Kim GM, Jeung HC, Kim D, Kim JH, Yoon SH, Jung ES, Shin SJ (2010a) A case of combined hepatocellular-cholangiocarcinoma with favorable response to systemic chemotherapy. Cancer Res Treat 42:235–238
Kim JH, Yoon HK, Ko GY, Gwon DI, Jang CS, Song HY, Shin JH, Sung KB (2010b) Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization. Radiology 255:270–277
Kim GJ, Kim H, Park YN (2013) Increased expression of Yes-associated protein 1 in hepatocellular carcinoma with stemness and combined hepatocellular-cholangiocarcinoma. PLoS One 8:e75449
Kim SH, Park YN, Lim JH, Choi GH, Choi JS, Kim KS (2014) Characteristics of combined hepatocellular-cholangiocarcinoma and comparison with intrahepatic cholangiocarcinoma. Eur J Surg Oncol 40:976–981
Kimoto T, Ugaki M (1982) Hepatocellular carcinoma combined with hepatic mesenchymal cell tumor and sarcoma. Acta Pathol Jpn 32:1131–1141
Koh KC, Lee H, Choi MS, Lee JH, Paik SW, Yoo BC, Rhee JC, Cho JW, Park CK, Kim HJ (2005) Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma. Am J Surg 189:120–125
Kojiro M, Kawano Y, Kawasaki H, Nakashima T, Ikezaki H (1982) Thorotrast-induced hepatic angiosarcoma, and combined hepatocellular and cholangiocarcinoma in a single patient. Cancer 49:2161–2164
Kondo Y, Nakajima T (1987) Pseudoglandular hepatocellular carcinoma. A morphogenetic study. Cancer 60:1032–1037
Koster H, Kasman LP (1932) Primary duplex liver carcinoma. Am J Surg 17:237–241
Kwon Y, Lee SK, Kim JS, Ro JY, Yu E (2002) Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules. Mod Pathol 15:1096–1101
L’Esperance E (1915) Atypical hemorrhagic malignant hepatoma. J Med Res 32:225–249
Larson CP (1937) Multiple liver-cell carcinoma (primary type). Report of a case. Northwest Med 36:388–391
Lee CC, Wu CY, Chen JT, Chen GH (2002) Comparing combined hepatocellular-cholangiocarcinoma and cholangiocarcinoma: a clinicopathologic study. Hepatogastroenterology 49:1487–1490
Lee WS, Lee KW, Heo JS, Kim SJ, Choi SH, Kim YI, Joh JW (2006) Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Surg Today 36:892–897
Lee JH, Chung GE, Yu SJ, Hwang SY, Kim JS, Kim HY, Yoon JH, Lee HS, Yi NJ et al (2011) Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma. J Clin Gastroenterol 45:69–75
Lee CH, Hsieh SY, Chang CJ, Lin YJ (2013) Comparison of clinical characteristics of combined hepatocellular-cholangiocarcinoma and other primary liver cancers. J Gastroenterol Hepatol 28:122–127
Leong AS, Sormunen RT, Tasui WM, Liew CT (1998) Hep Par 1 and selected antibodies in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma, combined tumours and metastatic carcinoma. Histopathology 33:318–324
Li X, Jiang W, Feng T, Wang Z (2012) Concurrent occurrence of primary hepatocellular and cholangiocellular carcinoma in the different part of the liver: a case report. Int J Clin Exp Med 5:355–357
Libbrecht L (2006) Hepatic progenitor cells in human liver tumor development. World J Gastroenterol 12:6261–6265
Lin G, Toh CH, Wu RC, Ko SF, Ng SH, Chou WC, Tseng JH (2008) Combined hepatocellular and cholangiocarcinoma: prognostic factors investigated by computed tomography/magnetic resonance imaging. Int J Clin Pract 62:1199–1205
Maarouf A, Adham M, Scoazec JY, Partensky C (2008) Mixed hepato/cholangiocarcinoma with paraneoplastic hypercalcemia. J Hepatobiliary Pancreat Surg 15:224–227
Maeda T, Adachi E, Kajiyama K, Sugimachi K, Tsuneyoshi M (1995) Combined hepatocellular and cholangiocarcinoma: proposed criteria according to cytokeratin expression and analysis of clinicopathologic features. Hum Pathol 26:956–964
Maeda A, Ebata T, Matsunaga K, Kanemoto H, Bando E, Yamaguchi S, Furukawa H, Uesaka K (2005) Primary liver cancer with bidirectional differentiation into hepatocytes and biliary epithelium. J Hepatobiliary Pancreat Surg 12:484–487
Matsumoto M, Wakiyama S, Shiba H, Gocho T, Misawa T, Ishida Y, Itsubo M, Suzuki M, Yanaga K (2014) Combined hepatocellular-cholangiocarcinoma producing parathyroid hormone-related protein: report of a case. Surg Today 44:1577–1583
Moon VH (1929) Primary carcinoma of liver with metastasis to bone. Arch Path 8:938–943
Morita D, Kagata Y, Ogata S, Tsuda H, Hatsuse K, Mochizuki H, Matsubara O (2006) Combined hepatocellular carcinoma and cholangiocarcinoma with components of mucinous carcinoma arising in a cirrhotic liver. Pathol Int 56:222–226
Murakami T, Yano H, Maruiwa M, Sugihara S, Kojiro M (1987) Establishment and characterization of a human combined hepatocholangiocarcinoma cell line and its heterologous transplantation in nude mice. Hepatology 7:551–556
Murata M, Miyoshi Y, Iwao K, Wada H, Shibata K, Tateishi H, Shimano T, Ohasawa M et al (2001) Combined hepatocellular/cholangiocellular carcinoma with sarcomatoid features: genetic analysis for histogenesis. Hepatol Res 21:220–227
Nakajima T, Kubosawa H, Kondo Y, Konno A, Iwama S (1988) Combined hepatocellular-cholangiocarcinoma with variable sarcomatous transformation. Am J Clin Pathol 90:309–312
Nakamura S, Suzuki S, Sakaguchi T, Serizawa A, Konno H, Baba S, Baba S, Muro H (1996) Surgical treatment of patients with mixed hepatocellular carcinoma and cholangiocarcinoma. Cancer 78:1671–1676
Nakasho K, Yamanaka N, Okamoto E (1996) A case of combined or mixed hepatocellular and cholangiocarcinoma with sarcomatous components – immunohistochemical characteristics and histogenesis (in Japanese). Nihon Shokakibyo Gakkai Zasshi 93:206–211
Neumann MA (1944) Primary carcinoma of the liver with metastases to bone. Am J Pathol 20:895–909
Ng IO, Shek TW, Nicholls J, Ma LT (1998) Combined hepatocellular-cholangiocarcinoma: a clinicopathological study. J Gastroenterol Hepatol 13:34–40
Nishie A, Yoshimitsu K, Asayama Y, Irie H, Aibe H, Tajima T, Shinozaki K, Nakayama T et al (2005) Detection of combined hepatocellular and cholangiocarcinomas on enhanced CT: comparison with histologic findings. AJR Am J Roentgenol 184:1157–1162
O’Connor K, Walsh JC, Schaeffer DF (2014) Combined hepatocellular-cholangiocarcinoma (cHCC-CC): a distinct entity. Ann Hepatol 13:317–322
Okada Y, Jinno K, Moriwaki S, Morichika S, Torigoe S, Arima T, Nagashima H, Koprowski H (1987) Expression of ABH and Lewis blood group antigens in combined hepatocellular –cholangiocarcinoma. Possible evidence for the hepatocellular origin of combined hepatocellular-cholangiocarcinoma. Cancer 60:345–352
Omagari K, Makiyama K, Ikuno N (1995) Combined hepatocellular and cholangiocarcinoma (in Japanese). Ryoikibetsu Shokogun Shirizu 7:473–475
Panjala C, Senecal DL, Bridges MD, Kim GP, Nakleh RE, Nguyen JH, Harnois DM (2010) The diagnostic conundrum and liver transplantation outcome for combined hepatocellular-cholangiocarcinoma. Am J Transplant 10:1263–1267
Papotti M, Sambataro D, Marchesa P, Negro F (1997) A combined hepatocellular/cholangiocellular carcinoma with sarcomatoid features. Liver 17:47–52
Park H, Choi KH, Choi SB, Choi JW, Kim do Y, Ahn SH, Kim KS, Choi JS, Han KH, Chon CY, Park JY (2011a) Clinicopathological characteristics in combined hepatocellular-cholangiocarcinoma: a single center study in Korea. Yonsei Med J 52:753–760
Park HS, Bae JS, Jang KY, Lee JH, Yu HC, Jung JH, Cho BH, Chung MJ, Moon WS (2011b) Clinicopathologic study on combined hepatocellular carcinoma and cholangiocarcinoma: with emphasis on the intermediate cell morphology. J Korean Med Sci 26:1023–1030
Pérez-Roldan F, Carretero L, Aguirre A, Banares R, Casado M, Cos E, Clemente G (1995) Hepato-cholangiocarcinoma with diffuse metastases and hypercalcemia (in Spanish). Rev Esp Enferm Dig 87:743–747
Phongkikarun S, Srisuwan T, Sornmayura P, Jatchavala J (2007) Combined hepatocellular and cholangiocarcinoma: CT findings with emphasis on multiphasic helical CT. J Med Assoc Thai 90:113–120
Portolani N, Baiocchi GL, Coniglio A, Piardi T, Grazioli L, Benetti A, Ferrari Bravo A, Giulini SM (2008) Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience. Ann Surg Oncol 15:1880–1890
Prescott WH (1895) Seven cases of primary carcinoma of the liver. Med Surg Rep Boston City Hosp 6:245–267
Pua U, Low SC, Tan YM, Lim KH (2009) Combined hepatocellular and cholangiocarcinoma with sarcomatoid transformation: radiologic-pathologic correlation of a case. Hepatol Int 3:587–592
Rasario GM (1934) Adeno-carcinoma epatocellulare primitive del fegato. Riv di Clin Med 35:767–786
Rasario GM (1937) Ulteriore contributo allo studio clinico ed anatomo-patologico della cancro-cirrosi del fegato. Clin Med Ital 68:807–817
Robrechts C, De Vos R, Van den Heuvel M, Van Cutsem F, Van Damme B, Desmet V, Roskams T (1998) Primary liver tumour of intermediate (hepatocyte-bile duct cell) phenotype: a progenitor cell tumour? Liver 18:288–293
Rosa M, Mohammadi A (2014) Cytologic features of fibrolamellar carcinoma with mucin production: a rare variant of combined hepatocellular-cholangiocarcinoma. Diagn Cytopathol 42:431–435
Saboo SS, Krajewski KM, Jagannathan JP, O’Regan KN, Odze R, Ramaiya N, Wolpin BM (2011) Rapid progression of combined hepatocellular carcinoma and cholangiocarcinoma. Cancer Imaging 11:37–41
Saito M, Hige S, Takeda H, Tomaru U, Shibata M, Asaka M (2001) Combined hepatocellular carcinoma and cholangiocarcinoma growing into the common bile duct. J Gastroenterol 36:842–847
Sanada Y, Shiozaki S, Aoki H, Takakura N, Yoshida K, Yamaguchi Y (2005) A clinical study of 11 cases of combined hepatocellular-cholangiocarcinoma. Assessment of enhancement patterns on dynamics computed tomography before resection. Hepatol Res 32:185–195
Sapisochin G, Fidelman N, Roberts JP, Yao FY (2011) Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma. Liver Transpl 17:934–942
Sasaki M, Nakanuma Y, Ho SB, Kim YS (1998) Cholangiocarcinomas arising in cirrhosis and combined hepatocellular-cholangiocellular carcinomas share apomucin profiles. Am J Clin Pathol 109:302–308
Sasaki A, Kawano K, Aramaki M, Ohno T, Tahara K, Takeuchi Y, Yoshida T, Kitano S (2001) Clinicopathologic study of mixed hepatocellular and cholangiocellular carcinoma: modes of spreading and choice of surgical treatment by reference to macroscopic type. J Surg Oncol 76:37–46
Sasaki M, Sato H, Kakuda Y, Sato Y, Choi JH, Nakanuma Y (2014) Clinicopathological significance of ‘subtypes with stem-cell feature’ in combined hepatocellular-cholangiocarcinoma. Liver Int. doi:10.1111/liv.12563
Shetty AS, Fowler KJ, Brunt EM, Agarwal S, Narra VR, Menias CO (2014) Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma. Abdom Imaging 39:310–322
Shin CI, Lee JM, Kim SH, Choi JY, Lee JY, Han JK, Jo SY, Choi BI (2007) Recurrence patterns of combined hepatocellular-cholangiocarcinoma on enhanced computed tomography. J Comput Assist Tomogr 31:109–115
Shiomi S, Sasaki N, Kawashima D, Jomura H, Fukuda T, Kuroki T, Koyama K, Kawabe J et al (1999) Combined hepatocellular carcinoma and cholangiocarcinoma with high F-18 fluorodeoxyglucose positron emission tomographic uptake. Clin Nucl Med 24:370–371
Shiraishi M, Takushi Y, Simoji H, Oshiro T, Shinzato S, Tanigawa N, Kusano T, Muto Y (1998) Combined hepatocellular and cholangiocellular carcinoma in a non-cirrhotic liver. J Gastroenterol 33:593–596
Shirakawa H, Kuronuma T, Nishimura Y, Hasebe T, Nakano M, Gotohda N, Takahashi S et al (2009) Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer. Int J Oncol 34:649–656
Singh S, Chakraborty S, Bonthus N, Radio S, Hussain SM, Sasson A (2013) Combined hepatocellular cholangiocarcinoma: a case report and review of literature. Dig Dis Sci 58:2114–2123
Sonobe H, Hayashi K, Takahashi K, Ohtsuki Y, Matsumoto K, Ohnishi S, Jinno K (1987) Combined hepatocellular and cholangiocarcinoma arising in a cirrhotic liver. Report of an autopsy case. Acta Pathol Jpn 37:1945–1952
Sugihara S, Nakahara T, Maruiwa M, Kojiro M, Iwai I, Tanaka M, Hirai K, Majima Y et al (1987) An autopsy case with a combination of hepatocellular carcinoma and cholangiocellular carcinoma (in Japanese). Gan No Rinsho 33:205–210
Taguchi J, Nakashima O, Tanaka M, Hisaka T, Takazawa T, Kojiro M (1996) A clinicopathological study on combined hepatocellular and cholangiocarcinoma. J Gastroenterol Hepatol 11:758–764
Tanaka T, Imamura A, Hayashi S, Tsuruta K, Igari T, Koike M, Tanaka S (1998) Minute mixed hepatoma with two components: hepatocellular and cholangiocarcinoma which developed on liver cirrhosis with HCV. Hepatogastroenterology 45:220–223
Tanaka S, Hirohashi K, Uenishi T, Yamamoto T, Hamba H, Kubo S, Tanaka H, Shuto T et al (2004) A mixed hepatocellular carcinoma and cholangiocarcinoma: dual expression of biliary-type cytokeratin and hepatocyte specific marker. Hepatogastroenterology 51:839–841
Tanaka K, Honna T, Kitano Y, Kuroda T, Tanaka K, Morikawa N, Matsuda H, Kawashima N et al (2005a) Combined fibrolamellar carcinoma and cholangiocarcinoma exhibiting biphenotypic antigen expression: a case report. J Clin Pathol 58:884–887
Tanaka S, Yamamoto T, Tanaka H, Kodai S, Ogawa M, Ichikawa T, Hai S, Sakabe K et al (2005b) Potentiality of combined hepatocellular and intrahepatic cholangiocellular carcinoma originating from a hepatic precursor cell: immunohistochemical evidence. Hepatol Res 32:52–57
Tang D, Nagano H, Nakamura M, Wada H, Marubashi S, Miyamoto A, Takeda Y, Umeshita K et al (2006) Clinical and pathological features of Allen’s type C classification of resected combined hepatocellular and cholangiocarcinoma: a comparative study with hepatocellular carcinoma and cholangiocellular carcinoma. Gastrointest Surg 10:987–998
Terada T (2013) Combined hepatocellular-cholangiocarcinoma with stem cell features, ductal plate malformation subtype: a case report and proposal of a new subtype. Int J Clin Exp Pathol 6:737–748
Theise ND, Yao JL, Harada K, Hytiroglou P, Portmann B, Thung SN, Tsui W, Ohta H, Nakanuma Y (2003) Hepatic ‘stem cell’ malignancies in adults: four cases. Histopathology 43:263–271
Theise ND, Nakashima O, Park YN, Nakanuma Y (2010) Combined hepatocellular-cholangiocarcinoma. WHO classification of tumours of the digestive system, 4th edn. IARC, Lyon, pp 225–227
Tickoo SK, Zee SY, Obiekwe S, Xiao H, Koea J, Robiou C, Blumgart LH, Jarnagin W et al (2002) Combined hepatocellular-cholangiocarcinoma. A histopathologic, immunohistochemical, and in situ hybridization study. Am J Surg Pathol 26:989–997
Toh CH, Cheung YC, Ng SH, Lin CY, Chan SC, Ng KK (2004) Combined hepatocellular-cholangiocarcinoma: a case report. Int J Clin Pract 58:1170–1173
Tomimatsu M, Ishiguro N, Taniai M, Okuda H, Saito A, Obata H, Yamamoto M, Takasaki K et al (1993) Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan. Cancer 72:683–688
Tramontano V, Fittipaldi C (1930) Sui cosidetti tumori a cellule giganti. Tumori 16:501–518
Tsuneyama K, Kaizaki Y, Doden K, Kidani E, Harada K, Sasaki M, Nakanuma Y (2003) Combined hepatocellular and cholangiocarcinoma with marked squamous cell carcinoma components arising in non-cirrhotic liver. Pathol Int 53:90–97
Uenishi T, Hirohashi K, Shuto T, Yamamoto T, Kubo S, Tanaka H, Ikebe T, Kinoshita H (2000) Surgery for mixed hepatocellular and cholangiocellular carcinoma. Hepatogastroenterology 47:832–834
Uenishi T, Hirohashi K, Shuto T, Tsukamoto T, Yamamoto T, Ogawa M, Kubo S, Tanaka H et al (2002) Primary liver cancer with dual expression of hepatocyte and bile duct epithelial markers. Hepatogastroenterology 49:1092–1094
Utsunomiya T, Saitsu H, Saku M, Takeshita M, Yoshida K, Kajiyama K, Sugimachi K (2000) A resected case of combined hepatocellular carcinoma and cholangiocarcinoma associated with cystic formation. Hepatogastroenterology 47:851–854
Van Eyken P, Sciot R, Brrock P, Casteels-Van Daele M, Ramaekers FCS, Desmet VJ (1990) Abundant expression of cytokeratin 7 in fibrolamellar carcinoma of the liver. Histopathology 17:101–107
Varnholt H, Asayama Y, Aishima S, Taguchi K, Sugimachi K, Tsuneyoshi M (2002) C-met and hepatocyte growth factor expression in combined hepatocellular and cholangiocarcinoma. Oncol Rep 9:35–41
Wachtel MS, Zhang Y, Xu T, Chiriva-Internati M, Frezza EE (2008) Combined hepatocellular cholangiocarcinomas; analysis of a large database. Clin Med Pathol 1:43–47
Wada K, Kondo F, Kubosawa H, Kondo Y (1986) Combined hepatocellular and mucinous carcinoma. Acta Pathol Jpn 36:285–291
Wakasa T, Wakasa K, Shutou T, Hai S, Kubo S, Hirohashi K, Umshita K, Monden M (2007) A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma. Hepatogastroenterology 54:508–513
Wang J, Wang F, Kessinger A (2010) Outcome of combined hepatocellular and cholangiocarcinoma of the liver. J Oncol 2010 pii:917356. doi:10.1155/2010/917356
Ward SC, Huang J, Tickoo SK, Thung SN, Ladanyi M, Klimstra DS (2010) Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation. Mod Pathol 23:1180–1190
Warvi WN (1944) Primary neoplasms of the liver. Arch Pathol 37:367–382
Wee A, Nilsson B (1999) Combined hepatocellular-cholangiocarcinoma. Diagnostic challenge in hepatic fine needle aspiration biopsy. Acta Cytol 43:131–138
Wells HG (1903) Primary carcinoma of the liver. Am J Med Sci 126:403–417
Willekens I, Hoorens A, Geers C, Op de beeck B, Vandenbroucke F, de mey J (2009) Combined hepatocellular and cholangiocellular carcinoma presenting with radiological characteristics of focal nodular hyperplasia. World J Gastroenterol 15:3940–3943
Wu PC, Fang JW, Lau VK, Lai CL, Lo CK, Lau JY (1996) Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications. Am J Pathol 149:1167–1175
Yano H, Iemura A, Haramaki M, Momosaki S, Ogasawara S, Higaki K, Kojiro M (1996) A human combined hepatocellular and cholangiocarcinoma cell line (KMCH-2) that shows the features of hepatocellular carcinoma or cholangiocarcinoma under different growth conditions. J Hepatol 24:413–422
Yano Y, Yamamoto J, Kosuge T, Sakamoto Y, Yamasaki S, Shimada K, Ojima H et al (2003) Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases. Jpn J Clin Oncol 33:283–287
Yarze JC, Herlihy KJ, Scalia SV (2005) Cholangiohepatoma presenting with recurrent cholangitis. Dig Dis Sci 50:552–553
Yeh MM (2010) Pathology of combined hepatocellular-cholangiocarcinoma. J Gastroenterol Hepatol 25:1485–1492
Yoshida T, Okazaki N, Yoshino M, Moriyama N, Hirohashi S (1985) A case of diffuse type of combined hepatocellular and cholangiocellular carcinoma initially presenting as a localized small nodule. Jpn J Cancer Res 76:1186–1192
Zhan Q, Shen BY, Deng XX, Zhu ZC, Chen H, Peng CH, Li HW (2012) Clinical and pathological analysis of 27 patients with combined hepatocellular-cholangiocarcinoma in an Asian center. J Hepatobiliary Pancreat Sci 19:361–369
Zhang F, Chen XP, Zhang W, Dong HH, Xiang S, Zhang WG, Zhang BX (2008) Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence. Histopathology 52:224–232
Zhou YM, Yang JM, Wang B, Xu F, Tong Y, Li DQ (2007) Combined hepatocellular carcinoma and cholangiocarcinoma: a case report and review of the literature. Hepatobiliary Pancreat Dis Int 6:656–659
Zhou YM, Zhang XF, Wu LP, Sui CJ, Yang JM (2014) Risk factors for combined hepatocellular-cholangiocarcinoma: a hospital-based case-control study. World J Gastroenterol 20:12615–12620
Zuo HQ, Yan LN, Zeng Y, Yang JY, Luo HZ, Liu JW, Zhou LX (2007) Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma. Hepatobiliary Pancreat Dis Int 6:161–165
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this entry
Cite this entry
Zimmermann, A. (2017). Combined Hepatocellular-Cholangiocarcinoma. In: Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. Springer, Cham. https://doi.org/10.1007/978-3-319-26956-6_26
Download citation
DOI: https://doi.org/10.1007/978-3-319-26956-6_26
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-26954-2
Online ISBN: 978-3-319-26956-6
eBook Packages: MedicineReference Module Medicine